Form 8-K - Current report:
SEC Accession No. 0001213900-23-031309
Filing Date
2023-04-20
Accepted
2023-04-20 16:05:17
Documents
13
Period of Report
2023-04-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea177239-8k_chinapharm.htm   iXBRL 8-K 24998
2 AMENDMENT TO CONVERTIBLE PROMISSORY NOTE DATED APRIL 13, 2023 ea177239ex10-1_chinapharm.htm EX-10.1 23785
  Complete submission text file 0001213900-23-031309.txt   230648

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cphi-20230413.xsd EX-101.SCH 2950
4 XBRL LABEL FILE cphi-20230413_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE cphi-20230413_pre.xml EX-101.PRE 22353
7 EXTRACTED XBRL INSTANCE DOCUMENT ea177239-8k_chinapharm_htm.xml XML 3714
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34471 | Film No.: 23833125
SIC: 2834 Pharmaceutical Preparations